Injectable GLP-1 formulations (subcutaneous semaglutide, tirzepatide) do not have this timing issue since they bypass the gastrointestinal tract for absorption
Furthermore, according to the results of a prospective cohort study, higher dietary inulin intake also failed to reduce the incidence of CKD and cardiovascular disease in the population, but prevented hypertension and T2DM, which are major risk factors for cardiovascular and renal events (161)
All of the five therapeutic GLP-1RAs, currently approved for therapy of type 2 diabetes, are peptide molecules, which are administered in subcutaneous injections
Plan the exit before you plan the start
Contact your physician or go to the ER if you experience: Vomiting lasting more than 24 hours, preventing you from keeping fluids down Dehydration signs such as dizziness, dry mouth, rapid heartbeat, or dark urine Sharp, constant upper abdominal pain, especially if it radiates to your back Fever, jaundice (yellowing of the skin or eyes), or bloody vomit/stool Confusion, extreme fatigue, or fainting Most individuals can manage GLP-1 side effects at home, but knowing when to seek further care is essential
Understand the realistic timeline for results